Abstract
Oncostatin M (OSM) is a pleiotropic cytokine with potential utility as a treatment for inflammatory arthritis. This pro-inflammatory cytokine is increased in the rheumatoid but not in the...
Cite
CITATION STYLE
APA
Barnes, T. C., & Moots, R. J. (2009). Targeting oncostatin M in the treatment of rheumatoid arthritis. In New Therapeutic Targets in Rheumatoid Arthritis (pp. 181–191). Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8238-4_10
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free